Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study.  | Zenas Biopharma’s lead autoimmune drug ...
Multiple sclerosis (MS) is an autoimmune condition in which the protective insulation surrounding ... | Cell And Molecular ...
Multiple sclerosis and Alzheimer's disease each affect women more often than men, about two to three times as often, ...
Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).
New Delhi, October 16 (IANS): US researchers have identified a gene on the X chromosome that drives inflammation in the ...
Being diagnosed with multiple sclerosis can often be an isolating experience, and even more so for those in Darwin who lack ...
Selma Blair’s lifelong health struggles were signs of multiple sclerosis that doctors wouldn't acknowledge until she was in ...